Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rigel Pharmaceuticals Inc...

    NASDAQ: RIGL · Real-Time Price · USD
    39.22
    1.33 (3.51%)
    At close: Aug 15, 2025, 2:34 PM

    Rigel Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 179.28M 116.88M 120.24M 149.24M
    Cost of Revenue
    		 18.65M 7.11M 1.75M 1.08M
    Gross Profit
    		 160.63M 109.77M 118.49M 148.15M
    Operating Income
    		 24.19M -20.49M -55.55M -8.97M
    Interest Income
    		 2.09M 2.27M 684K 47K
    Pretax Income
    		 18.37M -25.09M -58.57M -17.31M
    Net Income
    		 17.48M -25.09M -58.57M -17.91M
    Selling & General & Admin
    		 113.06M 105.74M 112.45M 91.89M
    Research & Development
    		 23.38M 24.52M 60.27M 65.24M
    Other Expenses
    		 n/a n/a 1.32M n/a
    Operating Expenses
    		 136.44M 130.26M 172.72M 157.13M
    Interest Expense
    		 7.92M 6.87M 3.71M 4.86M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 155.09M 137.37M 174.47M 158.21M
    Income Tax Expense
    		 881K n/a n/a 605K
    Shares Outstanding (Basic)
    		 17.58M 17.4M 17.24M 17.05M
    Shares Outstanding (Diluted)
    		 17.69M 17.4M 17.24M 17.05M
    EPS (Basic)
    		 0.99 -1.44 -3.4 -1.05
    EPS (Diluted)
    		 0.99 -1.44 -3.4 -1.05
    EBITDA
    		 28.51M -16.98M -53.87M -11.29M
    EBIT
    		 26.28M -18.22M -54.87M -12.45M
    Depreciation & Amortization
    		 2.23M 1.24M 998K 1.16M

    Add to Watchlist